Literature DB >> 15377733

The role of norepinephrine in the behavioral and psychological symptoms of dementia.

Nathan Herrmann1, Krista L Lanctôt, Lyla R Khan.   

Abstract

The behavioral and psychological symptoms of dementia (BPSD) are common serious problems that are a major contributor to caregiver burden. Despite their significance, the underlying neurobiology of these disturbances is still unclear. This review examines the role of norepinephrine (NE) on BPSD, including depression, aggression, agitation and psychosis. A number of lines of evidence suggest that NE dysfunction leading to BPSD may result from increased NE activity and/or hypersensitive adrenoreceptors compensating for loss of NE neurons with progression of Alzheimer's disease (AD). With greater appreciation of the underlying neurobiology of behavioral and psychological symptoms of dementia (BPSD) more effective, rational, targeted pharmacotherapy will hopefully emerge.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15377733     DOI: 10.1176/jnp.16.3.261

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  34 in total

1.  Evaluation of [11C]TAZA for amyloid β plaque imaging in postmortem human Alzheimer's disease brain region and whole body distribution in rodent PET/CT.

Authors:  Min-Liang Pan; Meenakshi T Mukherjee; Himika H Patel; Bhavin Patel; Cristian C Constantinescu; M Reza Mirbolooki; Christopher Liang; Jogeshwar Mukherjee
Journal:  Synapse       Date:  2016-02-11       Impact factor: 2.562

2.  Acute hypoglycemia causes depressive-like behaviors in mice.

Authors:  Min Jung Park; Samuel W Yoo; Brian S Choe; Robert Dantzer; Gregory G Freund
Journal:  Metabolism       Date:  2011-08-04       Impact factor: 8.694

3.  Genotype-independent decrease in plasma dopamine beta-hydroxylase activity in Alzheimer's disease.

Authors:  Maja Mustapic; Paola Presecki; Nela Pivac; Ninoslav Mimica; Patrick R Hof; Goran Simic; Vera Folnegovic-Smalc; Dorotea Muck-Seler
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-02-13       Impact factor: 5.067

4.  Delusions and hallucinations are associated with worse outcome in Alzheimer disease.

Authors:  Nikolaos Scarmeas; Jason Brandt; Marilyn Albert; Georgios Hadjigeorgiou; Alexandros Papadimitriou; Bruno Dubois; Maria Sarazin; Davangere Devanand; Lawrence Honig; Karen Marder; Karen Bell; Domonick Wegesin; Deborah Blacker; Yaakov Stern
Journal:  Arch Neurol       Date:  2005-10

5.  Reduced tissue levels of noradrenaline are associated with behavioral phenotypes of the TgCRND8 mouse model of Alzheimer's disease.

Authors:  Beverly M Francis; Jimao Yang; Enid Hajderi; Mary E Brown; Bernadeta Michalski; Joanne McLaurin; Margaret Fahnestock; Howard T J Mount
Journal:  Neuropsychopharmacology       Date:  2012-04-11       Impact factor: 7.853

6.  Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer's disease.

Authors:  Paula T Trzepacz; Jeffrey Cummings; Thomas Konechnik; Tammy D Forrester; Curtis Chang; Ellen B Dennehy; Brian A Willis; Catherine Shuler; Linda B Tabas; Constantine Lyketsos
Journal:  Int Psychogeriatr       Date:  2012-12-21       Impact factor: 3.878

7.  Cognitive, anxiety and mood disorders in the fragile X-associated tremor/ataxia syndrome.

Authors:  James A Bourgeois; Jennifer B Cogswell; David Hessl; Lin Zhang; Michele Y Ono; Flora Tassone; Faraz Farzin; James A Brunberg; Jim Grigsby; Randi J Hagerman
Journal:  Gen Hosp Psychiatry       Date:  2007 Jul-Aug       Impact factor: 3.238

8.  On the origin of cortical dopamine: is it a co-transmitter in noradrenergic neurons?

Authors:  Paola Devoto; Giovanna Flore
Journal:  Curr Neuropharmacol       Date:  2006-04       Impact factor: 7.363

Review 9.  Long Road to Ruin: Noradrenergic Dysfunction in Neurodegenerative Disease.

Authors:  David Weinshenker
Journal:  Trends Neurosci       Date:  2018-02-20       Impact factor: 13.837

10.  β-amyloid redirects norepinephrine signaling to activate the pathogenic GSK3β/tau cascade.

Authors:  Fang Zhang; Mary Gannon; Yunjia Chen; Shun Yan; Sixue Zhang; Wendy Feng; Jiahui Tao; Bingdong Sha; Zhenghui Liu; Takashi Saito; Takaomi Saido; C Dirk Keene; Kai Jiao; Erik D Roberson; Huaxi Xu; Qin Wang
Journal:  Sci Transl Med       Date:  2020-01-15       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.